Announcement PDF BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 1 BPH Global Limited Suite 303, Level 3 365 Little Collins Street Melbourne, VIC, 3000 ACN: 009 104 330 BPH Global Ltd Notice of Extraordinary General Meeting Explanatory Statement | Proxy Form 11 September 2026 11:00 am (AEST) Address Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting. BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 2 Contents Venue and Voting Information................................................................................................................................... 2 Notice of Extraordinary General Meeting – Agenda and Resolutions........................................................................ 4 Notice of Extraordinary General Meeting – Explanatory Statement.......................................................................... 7 Glossary.................................................................................................................................................................... 14 Annexure A – Terms and conditions of Placement Options (Resolution 1) and Lead Manager Options (Resolution 2)........................................................................................................................................................... 16 Important Information for Shareholders about the Company’s EGM This Notice is given based on circumstances as at 11 August 2026. Should circumstances change, the Company will make an announcement on the ASX market announcements platform and on the Company’s website at https://bphglobal.com.au. Shareholders are urged to monitor the ASX announcements platform and the Company’s website. Venue and Voting Information The Extraordinary General Meeting of the Shareholders to which this Notice of Meeting relates will be held at 11:00 am (AEST) on 11 September 2026 at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000. Your vote is important The business of the Meeting affects your shareholding and your vote is important. Voting in person To vote in person, attend the Meeting on the date and at the place set out above. Voting by proxy To vote by proxy, please use one of the following methods: Online Lodge the Proxy Form online at https://investor.automic.com.au/#/loginsah by following the instructions: Login to the Automic website using the holding details as shown on the Proxy Form. Click on ‘View Meetings’ – ‘Vote’. To use the online lodgement facility, Shareholders will need their holder number (Securityholder Reference Number (SRN) or Holder Identification Number (HIN)) as shown on the front of the Proxy Form. For further information on the online proxy lodgement process please see the Online Proxy Lodgement Guide at https://www.automicgroup.com.au/virtual-agms/ By post Automic, GPO Box 5193, Sydney NSW 2001 By hand Automic, Level 5, 126 Phillip Street, Sydney NSW 2000 By email Completing the enclosed Proxy Form and emailing it to: meetings@automicgroup.com.au Your Proxy instruction must be received by 11:00 am (AEST) on Wednesday, 9 September 2026, being not later than 48 hours before the commencement of the Meeting. Proxy Forms received later than this time will be invalid. BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 3 Power of Attorney If the proxy form is signed under a power of attorney on behalf of a shareholder, then the attorney must make sure that either the original power of attorney or a certified copy is sent with the proxy form, unless the power of attorney has already provided it to the Share Registry. Corporate Representatives If a representative of a corporate shareholder or a corporate proxy will be attending the Meeting, the representative should provide the Share Registry with adequate evidence of their appointment, unless this has previously been provided to the Share Registry. BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 4 Notice of Extraordinary General Meeting – Agenda and Resolutions Notice is hereby given that an Extraordinary General Meeting of Shareholders of BPH Global Ltd ACN 009 104 330 will be held at 11:00 am (AEST) on 11 September 2026 at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 (Meeting). The Explanatory Statement to this Notice of Meeting provides additional information on matters to be considered at the Meeting. The Explanatory Statement and the Proxy Form form part of this Notice of Meeting. The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 7pm AEST on 9 September 2026. Terms and abbreviations used in this Notice of Meeting and Explanatory Statement (Notice) are defined within the Notice and the Glossary. Agenda Resolution 1 – Approval to issue 250,000,000 Placement Options To consider and, if thought fit, to pass with or without amendment the following resolution as an Ordinary Resolution: ‘That, for the purposes of Listing Rule 7.1 and for all other purposes, Shareholders approve the issue of 250,000,000 Placement Options under Listing Rule 7.1, on the terms and conditions in the Explanatory Statement.’ A voting exclusion statement applies to this Resolution. Please see below. Resolution 2 – Approval to issue 107,750,000 Lead Manager Options To consider and, if thought fit, to pass with or without amendment the following resolution as an Ordinary Resolution: ‘That, for the purposes of Listing Rule 7.1 and for all other purposes, Shareholders approve the issue of 107,750,000 Lead Manager Options to Sanlam Private Wealth Pty Limited or its nominees under Listing Rule 7.1, on the terms and conditions in the Explanatory Statement.’ A voting exclusion statement applies to this Resolution. Please see below. Resolution 3 – Approval to Issue up to $1,000,000 worth of Shares To consider and, if thought fit, to pass with or without amendment the following resolution as an Ordinary Resolution: ‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, Shareholders authorise and approve the issue of up to the number of Shares determined by $1,000,000 divided by the Proposed Share Issue Price on the terms and conditions in the Explanatory Statement.’ A voting exclusion statement applies to this Resolution. Please see below. Resolution 4 – Approval of Share Consolidation To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: ‘That, for the purposes of section 254H of the Corporations Act and for all other purposes, the issued capital of the Company be consolidated on the terms and conditions set out in the Explanatory Statement and on the basis that: (a) every ten (10) Shares be consolidated into one (1) Consolidated Share; and (b) all Options and other convertible Securities on issue be consolidated in accordance with Listing Rule 7.22.1, and where this consolidation results in a fraction of a Security being held, the Company be authorised to round that fraction up to the nearest whole Security.’ BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 5 No voting exclusion applies to this Resolution, as the Share Consolidation applies equally to all Shareholders. Resolution 5 – Approval of Change of Company Name To consider and, if thought fit, to pass, as a Special Resolution, the following: ‘That, for the purpose of section 157(1)(a) of the Corporations Act and for all other purposes, approval is given for the Company’s name to be changed from BPH Global Ltd to “Ocean Sciences Ltd”.’ No voting exclusion applies to this Resolution. BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 6 Voting Prohibitions and Exclusions Resolutions 1, 2 and 3 Voting Exclusion Statement: The Company will disregard any votes cast in favour of Resolutions 1, 2 and 3 by or on behalf of any person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a Shareholder), or any of their respective associates. However, this does not apply to a vote cast in favour by: (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and (ii) the holder votes on the Resolution in accordance with direc- tions given by the beneficiary to the holder to vote in that way. Determination of voting entitlement For the purpose of determining a person’s entitlement to vote at the Meeting, a person will be recognised as a Shareholder and the holder of Shares if that person is registered as a holder of those Shares at 7pm AEST on 9 September 2026. Votes Voting on each resolution will be by way of a poll, every member present in person or by attorney or by proxy or, in the case of a body corporate, by a representative, shall have one vote for each share held by him, her or it. Proxies A Shareholder entitled to attend and vote is entitled to appoint a proxy to attend and vote instead of the Shareholder. A form of proxy accompanies this Notice. Questions and Comments by Shareholders A reasonable opportunity will be given to Shareholders to ask questions and/or make comments on the business of the Meeting. BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 7 Notice of Extraordinary General Meeting – Explanatory Statement This Explanatory Statement has been prepared for the information of the Shareholders in connection with the business to be conducted at the Extraordinary General Meeting to be held at 11:00 am (AEST) on 11 September 2026 at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000. The purpose of this Explanatory Statement is to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions in the Notice of Meeting. If you are in any doubt about what to do in relation to the Resolutions contained in the Notice of Meeting and this Explanatory Statement, it is recommended that you seek advice from an accountant, solicitor or other professional advisor. Resolution 1 – Approval to issue 250,000,000 Placement Options Background On 5 February 2026, the Company announced that it had received firm commitments to raise $1.0 million (before costs) through a strategic placement of 500,000,000 fully paid ordinary shares at an issue price of $0.002 per Share, completed at market price with no discount (Placement). The Placement introduced new, long-term shareholders aligned with the Company’s growth strategy. The Placement Shares were issued to sophisticated and professional investors pursuant to a resolution approved by Shareholders at the Company’s 2025 Annual General Meeting, and rank equally with the Company’s existing Shares on issue. Shareholder approval for the issue of the Placement Shares themselves has already been obtained and accordingly this Resolution does not seek ratification of those Shares. Under the terms of the Placement, participants are entitled to one (1) free attaching Option for every two (2) Placement Shares subscribed for. As 500,000,000 Placement Shares were issued, this equates to 250,000,000 Placement Options requiring Shareholder approval for issue at the Meeting. No Directors of the Company participated in the Placement, and no Placement Options the subject of this Resolution will be issued to a related party of the Company. The Placement Options will be exercisable at $0.004 each and will expire three (3) years from the date of issue. Proceeds from the Placement have been used to fund Indonesian-based seaweed operations, research and development initiatives and working capital. ASX Listing Rule 7.1 Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12-month period to 15% of the fully paid ordinary shares it had on issue at the start of that period. The issue of the Placement Options does not fit within any of the exceptions to Listing Rule 7.1. It therefore requires the approval of the Company’s Shareholders under Listing Rule 7.1. If Resolution 1 is passed, the Company will be able to proceed with the issue of up to 250,000,000 Placement Options, and the issue will be excluded from the calculation of the number of equity securities that the Company can issue without shareholder approval under Listing Rule 7.1. If Resolution 1 is not passed, the Company will not be able to proceed with the issue of the Placement Options. Specific information required by Listing Rule 7.3 Pursuant to and in accordance with Listing Rule 7.3, the following information is provided in relation to Resolution 1: a) The Placement Options will be issued to the participants in the Placement referred to above (Placement Participants), being sophisticated and professional investors, none of whom is a related party or a member of the BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 8 Company’s key management personnel or an advisor to the Company or an associate of any of these parties or a substantial shareholder (>10%). b) A maximum of 250,000,000 Placement Options will be issued pursuant to this Resolution. c) The Placement Options will be exercisable at $0.004 each and will expire three (3) years from the date of issue. The Company will apply for ASX quotation of the Placement Options. Full terms of the Placement Options are set out in Annexure A. d) The Placement Options will be issued no later than 3 months after the date of the Meeting. e) The Placement Options are proposed to be issued for nil cash consideration as they are free-attaching to the Placement Shares (on a 1 Option for every 2 Shares basis). Accordingly, no funds will be raised from the issue of the Options. Any funds raised upon exercise of the Options will be used towards general working capital purposes. f) Proceeds from the Placement have been used to fund Indonesian-based seaweed operations, research and development initiatives and working capital. g) There are no other material terms to the agreement for the subscription of the Placement Options. h) A voting exclusion statement is included in the Notice. Directors’ Recommendation The Board recommends that Shareholders vote in favour of Resolution 1. Resolution 2 – Approval to issue 107,750,000 Lead Manager Options Background Sanlam Private Wealth Pty Ltd ABN 18 136 960 775, AFSL No 337927 (Sanlam) acted as Lead Manager and Adviser to the Placement referred to under Resolution 1. In consideration for its services, the Company agreed to remunerate the brokers who assisted in raising the funds by way of a capital raising fee of up to 6% (plus GST) and the issue of options on the same terms as the Placement. This Resolution seeks Shareholder approval for the issue of 107,750,000 of those Options to Sanlam Private Wealth Pty Limited or its nominees (Lead Manager Options), comprising 50,000,000 Options in respect of previous advisory work done for the Company and 57,750,000 Options in connection with the Placement. The Lead Manager Options will be exercisable at $0.004 each and will expire three (3) years from the date of issue. ASX Listing Rule 7.1 A summary of Listing Rule 7.1 is set out above under Resolution 1. The issue of the Lead Manager Options does not fit within any of the exceptions to Listing Rule 7.1. It therefore requires the approval of the Company’s Shareholders under Listing Rule 7.1. If Resolution 2 is passed, the Company will be able to proceed with the issue of up to 107,750,000 Lead Manager Options, and the issue will be excluded from the calculation of the number of equity securities that the Company can issue without shareholder approval under Listing Rule 7.1. If Resolution 2 is not passed, the Company will not be able to proceed with the issue of the Lead Manager Options and may need to consider alternative means to compensate the lead manager for its services, which may include paying additional cash. Specific information required by Listing Rule 7.3 a) The 107,750,000 Lead Manager Options will be issued to Sanlam Private Wealth Pty Limited and/or its nominees, who acted as Lead Manager and Adviser to the Placement and are not a related party or a member of the Company’s key management personnel or an associate of any of these parties or a substantial shareholder (>10%). BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 9 b) A maximum of 107,750,000 Lead Manager Options will be issued pursuant to this Resolution. c) The Lead Manager Options will be exercisable at $0.004 each and will expire three (3) years from the date of issue. The Company will apply for ASX quotation of the Lead Manager Options. Full terms of the Placement Options are set out in Annexure A. d) The Lead Manager Options will be issued no later than 3 months after the date of the Meeting. e) The Lead Manager Options will be issued for nil cash consideration, as consideration for lead manager and advisory services. Accordingly, no funds will be raised from the issue. f) Sanlam was engaged as Lead Manager and Adviser to the Placement, remunerated by way of a capital raising fee of up to 6% (plus GST) of funds raised together with the issue of Lead Manager Options. g) A voting exclusion statement is included in the Notice. Directors’ Recommendation The Board recommends that Shareholders vote in favour of Resolution 2. Resolution 3 – Approval to Issue up to $1,000,000 worth of Shares Background Resolution 3 seeks Shareholder approval pursuant to and in accordance with Listing Rule 7.1 (and for all other purposes) for the issue of that number of Shares determined by $1,000,000 divided by the proposed Share issue price (Proposed Shares) (Proposed Share Issue). ASX Listing Rule 7.1 A summary of Listing Rule 7.1 is set out above under Resolution 1. The issue of the Proposed Shares does not fall within any of the exceptions to Listing Rule 7.1 and, as it has not been approved by Shareholders, it effectively uses up part of the Company’s 15% Placement Capacity, reducing the Company’s capacity to issue further Equity Securities without Shareholder approval under Listing Rule 7.1 for the 12-month period following the issue of the Proposed Shares. If Resolution 3 is passed, the issue of the Proposed Shares can proceed without using any of the Company’s 15% Placement Capacity on issuing Equity Securities without Shareholder approval set out in Listing Rule 7.1. If Resolution 3 is not passed, the Company will not be able to proceed with the issue of the Proposed Shares and would have to rely on the Company’s remaining 15% (and 10%, if applicable) placement capacity, or alternative funding options, to raise additional funding for its business operations. Specific information required by Listing Rule 7.3 a) The Directors intend that the Proposed Shares will be issued to institutional or professional and sophisticated investors and clients of Australian stockbroking firms who are not related parties or key management personnel of the Company, advisors to the Company or substantial shareholders of the Company. b) The maximum number of Proposed Shares to be issued is up to that number of Shares which, when multiplied by the proposed Share issue price, equals $1,000,000. c) All Proposed Shares will be fully paid ordinary shares in the capital of the Company and will rank equally in all respects with the Company’s existing Shares on issue. d) The Proposed Shares will be issued no later than three months following the date of the Meeting. It is intended that the issue of the Proposed Shares will occur as part of a placement but may also occur progressively. e) The issue price per Proposed Share will not be more than a 30% discount to the 15 Trading Day VWAP as at the date of agreement to issue. BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 10 f) The proceeds from the Proposed Share Issue will be used to fund Indonesian-based seaweed operations, research and development initiatives and working capital. g) A voting exclusion statement is included in the Notice for Resolution 3. Directors’ Recommendation The Board recommends that Shareholders vote in favour of Resolution 3. Resolution 4 – Approval of Share Consolidation Background Under section 254H of the Corporations Act, a company may consolidate its shares if the consolidation is approved by an ordinary resolution of shareholders at a general meeting. The Company proposes to consolidate its share capital through the consolidation of every ten (10) Shares into one (1) Consolidated Share (Share Consolidation). The Share Consolidation ratio was determined so that the share price of the Company following implementation of the Share Consolidation would be approximately $0.02 per Share, based on the closing price of the Shares of $0.002 on 31 July 2026. If the Share Consolidation is approved, it is expected that it will take effect in accordance with the timetable set out below (subject to any changes announced to ASX). Effect on Shareholders As the Share Consolidation applies equally to all Shareholders, individual shareholdings will be reduced in the same ratio as the total number of Shares (subject only to the rounding of fractions). As such, the Share Consolidation will have no material effect on the percentage interest of each individual Shareholder. Similarly, other than minor changes as a result of rounding, the aggregate value of each Shareholder’s Shares (and the Company’s market capitalisation) should not change as a result of the Share Consolidation alone (that is, assuming no other market movements or impacts occur). Shareholders should note that the Share Consolidation, if approved, would also have an effect on the Company’s share price. The price per Share may increase proportionately to reflect the reduced number of Shares on issue (although this is not certain and may be impacted by market movements or other events). As noted above, the Company has chosen the ratio of 10:1 to achieve a price per Share of approximately $0.02. If the Resolution is passed, the Share Consolidation will be implemented and binding upon all Shareholders, regardless of how (or if) they vote on the Resolution. Reasons for Share Consolidation At the date of this Notice, the Company has a total of 2,353,484,651 Shares on issue. The Share Consolidation is expected to result in a more appropriate and effective capital structure for the Company and a more appealing share price to a wider range of investors and to bring the Company’s capital structure more in line with its peers on the ASX. Following implementation of the Share Consolidation, and based only on current Shares on issue, the Company expects there will be at least 235,348,466 Consolidated Shares on issue (rounded up to the nearest whole number for each holder and assuming no further share issues occur between the date of this Notice and the effective date for the Share Consolidation). If the consolidation is approved by Shareholders and if Resolutions 1 to 3 are also approved by Shareholders it is intended that the Options the subject of Resolutions 1 to 3 will be issued post completion of the consolidation and within three months of the date of the Meeting. As a result the maximum number of securities to be issued, as detailed in Resolutions 1 and 2 will be adjusted on the same basis as the consolidation as detailed below: BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 11 Resolution Pre-Consolidation Options and Exercise Price Post Consolidation Options and Exercise Price 1 250,000,000 Options Exercise Price: $0.004 25,000,000 Options Exercise Price: $0.04 2 107,750,000 Options Exercise Price: $0.004 10,775,000 Options Exercise Price: $0.04 The maximum number of Proposed Shares pursuant to Resolution 3 post consolidation is up to that number of Shares which, when multiplied by the proposed Share issue price, equals $1,000,000. Treatment of Fractions Where the consolidation of a Shareholder’s Shares (or Options or other Securities) results in an entitlement to a fraction of a Security, the fraction will be rounded up to the next whole number of Securities. Options At the date of this Notice, the Company has the following classes of Options on issue, comprising a total of 921,199,100 Options. Listing Rule 7.22 provides that, in a consolidation of capital, the number of options on issue must be consolidated in the same ratio as the entity’s ordinary capital and the exercise price must be amended in inverse proportion to that ratio. Accordingly, if this Resolution is passed, the Options will also be consolidated on a 10:1 basis, and the applicable exercise price will be revised upwards in inverse proportion to that ratio. The Options comprise: l 44,166,876 OPTIONS EXPIRING 07/07/2027 EX $0.05 l 1,020,000 OPTIONS EXPIRING 05/12/2028 EX $0.05 l 5,000,000 OPTIONS EXPIRING 01/11/2027 EX $0.25 l 1,000,000 OPTIONS EXPIRING 28/02/2027 EX $0.10 l 1,000,000 OPTIONS EXPIRING 28/02/2027 EX $0.085 l 100,000 OPTIONS EXPIRING 28/02/2027 EX $0.05 l 259,870,554 OPTIONS EXPIRING 11/12/2026 EX $0.02 l 17,500,001 OPTIONS EXPIRING 13/12/2027 EX $0.006 l 66,666,669 OPTIONS EXPIRING 28/02/2028 EX $0.006 l 136,125,000 OPTIONS EXPIRING 02/12/2027 EX $0.006 l 388,750,000 OPTIONS EXPIRING 04/12/2027 EX $0.004 Pre-consolidation Post-consolidation No. of options 44,166,876 (ASX:BP8O) No. of options 4,416,688 Exercise Price $0.05 Exercise Price $0.50 No. of options 1,020,000 (ASX:BP8AA) No. of options 102,000 Exercise Price $0.05 Exercise Price $0.50 No. of options 121,714,054 (ASX:BP8AA) No. of options 12,171,406 Exercise Price $0.02 Exercise Price $0.20 No. of options 5,000,000 (ASX:BP8AJ) No. of options 500,000 Exercise Price $0.25 Exercise Price $2.50 BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 12 Pre-consolidation Post-consolidation No. of options 1,000,000 (ASX:BP8AN) No. of options 100,000 Exercise Price $0.10 Exercise Price $1.00 No. of options 1,000,000 (ASX:BP8AM) No. of options 100,000 Exercise Price $0.085 Exercise Price $0.85 No. of options 100,000 (ASX:BP8AO) No. of options 10,000 Exercise Price $0.05 Exercise Price $0.50 No. of options 138,176,500 (ASX:BP8AD) No. of options 13,817,650 Exercise Price $0.02 Exercise Price $0.20 No. of options 17,500,001 (ASX:BP8AC) No. of options 1,750,001 Exercise Price $0.006 Exercise Price $0.06 No. of options 66,666,669 (ASX:BP8AV) No. of options 6,666,667 Exercise Price $0.006 Exercise Price $0.06 No. of options 136,125,000 (ASX:BP8AE) No. of options 13,612,500 Exercise Price $0.006 Exercise Price $0.06 No. of options 388,750,000 (ASX:BP8AF) No. of options 38,875,000 Exercise Price $0.004 Exercise Price $0.04 Performance Rights At the date of this Notice, the Company also has 60,000,000 Performance Rights (Class A) and 60,000,000 Performance Rights (Class B) on issue, each expiring 4 December 2030. Performance Rights entitle the holder to receive one Share for nil consideration upon satisfaction of applicable vesting conditions, and do not have an exercise price. The Directors consider that Performance Rights fall within the definition of convertible Securities the subject of Resolution 4, and propose that the number of Performance Rights on issue be consolidated on the same 10:1 basis as Options, with fractions rounded up. As Performance Rights are not exercised for a cash amount, there is no exercise price to adjust. The vesting share price for Class A Performance Rights will be adjusted from $0.004 to $0.04 and the vesting share price for Class B Performance Rights will be adjusted from $0.006 to $0.06. Description Pre-Consolidation No. of Rights Pre-Consolidation Exercise Price Post- Consolidation No. of Rights Performance Rights (Class A) expiring 04/12/2030 60,000,000 Nil 6,000,000 Performance Rights (Class B) expiring 04/12/2030 60,000,000 Nil 6,000,000 120,000,000 12,000,000 Timetable If approved by Shareholders, the proposed Share Consolidation is intended to take effect in accordance with the following indicative timetable (subject to change): Key Event Indicative Date Entity announces Share Consolidation (Appendix 3A.3) and notices despatched to security holders 11 August 2026 BPH Global Limited | Notice of Extraordinary General Meeting and Explanatory Statement 13 Key Event Indicative Date Extraordinary General Meeting and notification to ASX that Share Consolidation is approved 11 September 2026 Effective date of consolidation (Effective Date) 11 September 2026 Last day for trading in pre-consolidation securities 14 September 2026 Trading in consolidated securities on a deferred settlement basis commences 15 September 2026 Last day to register transfers on a pre-consolidation basis (Record Date) 16 September 2026 First d